Last reviewed · How we verify
Influenza Vaccine 1
Influenza Vaccine 1 is a Biologic drug developed by ModernaTX, Inc.. It is currently in Phase 1 development.
At a glance
| Generic name | Influenza Vaccine 1 |
|---|---|
| Sponsor | ModernaTX, Inc. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
- Duplicate Vaccination
Key clinical trials
- Influenza A (H7N9) Vaccine Delivered Intradermally by High-density Microarray Patch (HD-MAP) (PHASE1)
- A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults (PHASE3)
- This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate Influenza (PHASE2)
- Long-term Observation of Hemagglutinin and Neuraminidase Inhibition Antibody Titers After Influenza Challenge
- A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above (PHASE2)
- A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults (PHASE1)
- Vaccine Pandemic Preparedness Through Airway Immunology Characterization (EARLY_PHASE1)
- Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Influenza Vaccine 1 CI brief — competitive landscape report
- Influenza Vaccine 1 updates RSS · CI watch RSS
- ModernaTX, Inc. portfolio CI
Frequently asked questions about Influenza Vaccine 1
What is Influenza Vaccine 1?
Influenza Vaccine 1 is a Biologic drug developed by ModernaTX, Inc..
Who makes Influenza Vaccine 1?
Influenza Vaccine 1 is developed by ModernaTX, Inc. (see full ModernaTX, Inc. pipeline at /company/modernatx-inc).
What development phase is Influenza Vaccine 1 in?
Influenza Vaccine 1 is in Phase 1.
What are the side effects of Influenza Vaccine 1?
Common side effects of Influenza Vaccine 1 include Duplicate Vaccination.
Related
- Manufacturer: ModernaTX, Inc. — full pipeline
- Compare: Influenza Vaccine 1 vs similar drugs
- Pricing: Influenza Vaccine 1 cost, discount & access